Ocugen, Inc. (OCGN)
1.39
-0.07
(-4.79%)
USD |
NASDAQ |
May 15, 16:00
1.40
+0.01
(+0.72%)
After-Hours: 20:00
Ocugen Total Liabilities (Quarterly) : 51.10M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| REGENXBIO, Inc. | 320.81M |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Sarepta Therapeutics, Inc. | 1.674B |
| Krystal Biotech, Inc. | 120.24M |
| Gilead Sciences, Inc. | 32.85B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.90M |
| Shareholders Equity (Quarterly) | 5.805M |
| Debt to Equity Ratio | 5.736 |
| Current Ratio | 1.862 |
| Net Debt Paydown Yield | -0.03% |